hotspot -WSS

hotspot

author：fashion 2025-09-30 18:59:08 - browse：138

Illustration of a teal cancer cell. -- health coverage from STAT — Illustration of a teal cancer cell. Adobe

Sana Biotechnology, a startup that just a couple of years ago raised over $1 billion off a grand plan to create a portfolio of powerful medicines, said Tuesday it would lay off nearly a third of its employees and de-prioritize one of its most ambitious programs as it looks to save money.

The layoffs are Sana’s second round of cuts in less than a year. It laid off 15% of staff last November after axing another program.

Tuesday’s move pushed back a program focused on turning a patient’s own immune cells into cancer-killing assassins or curing blood disorders such as sickle cell with just an IV infusion. Known as in vivo reprogramming, it was originally the company’s central focus and would have amounted to a monumental breakthrough.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medical leaders decry Supreme Court decision on affirmative action
Next article： Too many hospitalized Covid

leisure time

Wikipedia

WSS

DOJ reversal could clear way for Carroll's 1st lawsuit against Trump to proceed

Study gives hint on South Asians’ higher risk of cardiovascular disease

Dozens of Pride flags vandalized at Stonewall monument in NYC, 3rd time this month: Police

Resistance to opioid

Too many hospitalized Covid

Why 40% Americans with Parkinson’s don’t see a neurologist

knowledge

hotspot

Wikipedia

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Bulgari apologizes to China for listing Taiwan as a country after online backlash

Virginia high school admissions case could be legal follow

Retired US general questions alleged Putin, Prigozhin meeting

Walensky prepares to leave CDC — and Congress — behind

Congress considering partial increase for doctor pay in Medicare

Hepatitis C has a cure — but many Americans still lack access to it

Tome Biosciences co

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Readout Newsletter: Replicate, Biogen's Leqembi, and Humira

Wikipedia

Latigo launches with $135 million for Vertex

Oak trusses raised to roof of fire

Racing yachts have close encounter with pod of orcas near Strait of Gibraltar

Why 40% Americans with Parkinson’s don’t see a neurologist

Living with Fabry disease, a condition that causes chronic pain

Threats against the LGBTQIA+ community intensifying: Department of Homeland Security

hotspot

leisure time

Wikipedia

focus